MedPlus Health Services announced that its subsidiary, Optival Health Solutions Private Limited, received a suspension order for a Drug License covering one retail store in Telangana. The suspension is mandated for three days under the Drugs and Cosmetics Act, 1940. The company anticipates a Potential Revenue Loss of Rs 0.76 lacs due to this temporary halt in operations, which commenced following the order dated February 22, 2026.
Regulatory Action Against Subsidiary Store
MedPlus Health Services Limited has disclosed a recent regulatory action affecting one of its retail outlets operated by its subsidiary, Optival Health Solutions Private Limited. The Assistant Director, Drugs Control Administration in Shameerpet, Telangana, issued an order concerning a store located at Surya Nagar Colony Mallpur, Telangana.
Details of Suspension and Impact
The nature of the action taken was the Suspension of the Drug License for a duration of Three Days. The authority issued this directive based on alleged violations or contraventions of Rule 65 of Drugs and Cosmetics Act, 1940, and related Rules. The order was officially received by the company on February 22, 2026.
The immediate financial impact due to this temporary operational halt is estimated to be a Potential Revenue Loss of Rs 0.76 lacs. The company has confirmed that this operational disruption is not quantifiable in monetary terms beyond this immediate revenue projection.
Compliance and Disclosure
MedPlus stated that comprehensive details of this incident have been made publicly available on the company’s official website, along with the websites of the stock exchanges for full transparency regarding the disclosure requirements.
Source: BSE
